
National Atomic Company Kazatomprom JSC
Notes to the Consolidated Financial Statements – 31 December 2024
36
24 Investments in joint ventures (continued)
Summarised financial information on respect of the Group’s material joint ventures is set out below. The summarised financial information below represents amounts shown in the
joint ventures’ financial statements prepared in accordance with IFRS, adjusted by the Group for equity accounting purposes.
Semizbay-U LLP JV Budenovskoye LLP Ulba-FA LLP SKZ-U LLP Other Total In millions of Kazakhstani Tenge 2024 2023 2024 2023 2024 2023 2024 2023 2024 2023 2024 2023 Current assets 75,899 52,012 - 20,593 377,609 241,991 3,870 1,687 3,456 2,603 460,834 318,886 Including cash 5,034 29,571 - 11,885 52,683 739 1,003 109 840 229 59,560 42,533 Non-current assets 34,155 31,061 - 43,310 19,814 20,756 20,414 20,058 4,952 4,387 79,335 119,572 Total assets 110,054 83,073 - 63,903 397,423 262,747 24,284 21,745 8,408 6,990 540,169 438,458 Current liabilities (16,301) (11,512) - (11,936) (387,063) (213,927) (1,202) (1,955) (2,499) (2,140) (407,065) (241,470) Including financial liabilities net of trade and other accounts payable and provisions (7,952) (3,646) - (6,617) (12,616) (11,318) - - - - (20,568) (21,581) Non-current liabilities (7,316) (7,677) - (23,759) (13,410) (35,812) (2,728) (2,877) (39) (9) (23,493) (70,134) Including financial liabilities net of trade and other accounts payable and provisions (66) - - (22,633) (11,654) (20,182) - - - - (11,720) (42,815) Total liabilities (23,617) (19,189) - (35,695) (400,473) (249,739) (3,930) (4,832) (2,538) (2,149) (430,558) (311,604) Net assets 86,437 63,884 - 28,208 (3,050) 13,008 20,354 16,913 5,870 4,841 109,611 126,854 Group’s share of net assets of joint ventures 44,083 32,581 - 14,387 (1,556) 6,634 9,974 8,287 4,269 3,817 56,770 65,706 Goodwill 4,105 4,105 - - - - 90 90 (1,464) (1,464) 2,731 2,731 Share in accumulated unrecognized losses - - - - 1,556 - - - - - 1,556 - Impairment losses - - - - - - - - (21) (21) (21) (21) Other 132 131 - (1,258) - - - - 994 755 1,126 (372) Unrealised gain - - - (5,960) - - - - - - - (5,960) Unrealised profit (8,557) (5,499) - - - - - - - - (8,557) (5,499) Carrying value of investments in joint ventures 39,763 31,318 - 7,169 - 6,634 10,064 8,377 3,778 3,087 53,605 56,585 Total revenue 95,508 70,757 - 8,542 163,593 114,004 15,762 13,652 4,371 3,420 279,234 210,375 Depreciation and amortisation (7,869) (7,994) - (245) (984) (1,160) (1,341) (1,090) (403) (359) (10,597) (10,848) Finance income 752 712 - 150 6,188 1,300 167 20 34 30 7,141 2,212 Finance costs (1,178) (838) - (1,139) (1,113) (1,423) (16) (50) (1) (1) (2,308) (3,451) Foreign exchange gain/(loss) 2,509 (208) - (176) 2,818 - 2 110 - - 5,329 (274) Impairment losses (2,462) (218) - 10 6,354 - (41) (4) 3 (11) 3,854 (223) Income tax (12,612) (8,506) - (1,164) (1,027) (317) (1,017) (1,017) (9) (8) (14,665) (11,012) Profit/(loss) for the year 48,624 32,542 - 3,413 (16,058) 11,132 3,903 3,845 13 12 36,482 50,944 Other comprehensive loss (38) - - - - - - - (4) - (42) - Total comprehensive income/(loss) 48,586 32,542 - 3,413 (16,058) 11,132 3,903 3,845 9 12 36,440 50,944 Unrealised profit (3,058) (3,572) - - - - - - - - (3,058) (3,572) Share in accumulated unrecognised losses - - - - 1,556 - - - - - 1,556 - Share of results of joint ventures 21,741 13,025 - 1,741 (6,634) 5,677 1,912 1,884 11 9 17,030 22,336 Dividends received 13,277 9,959 - - - - 226 - - - 13,503 9,959